| # | Title | Journal | Year | Citations |
|---|
| 1 | Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic Metabolite | Pharmacology | 1974 | 2,682 |
| 2 | Glutathione S-Transferase Polymorphisms and Their Biological Consequences | Pharmacology | 2000 | 863 |
| 3 | Acetaminophen-induced Hepatic Necrosis | Pharmacology | 1974 | 509 |
| 4 | Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients | Pharmacology | 1980 | 446 |
| 5 | Effects of Cilostazol, a Selective cAMP Phosphodiesterase Inhibitor on the Contraction of Vascular Smooth Muscle | Pharmacology | 1988 | 435 |
| 6 | Historical View on Ergot Alkaloids | Pharmacology | 1978 | 413 |
| 7 | Acetaminophen-Induced Hepatic Necrosis V. Correlation of Hepatic Necrosis, Covalent Binding and Glutathione Depletion in Hamsters | Pharmacology | 1974 | 299 |
| 8 | Does REM Sleep Deprivation Induce a Supersensitivity of Dopaminergic Receptors in the Rat Brain? | Pharmacology | 1978 | 275 |
| 9 | The Disposition of Propranolol | Pharmacology | 1972 | 261 |
| 10 | Ornithine Decarboxylase as a Biological and Pharmacological Tool | Pharmacology | 1980 | 244 |
| 11 | Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminée | Pharmacology | 1960 | 213 |
| 12 | The Energy Cost of the Metabolism of Drugs, Including Ethanol | Pharmacology | 1972 | 211 |
| 13 | The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize | Pharmacology | 2008 | 205 |
| 14 | Rebound Insomnia and Rebound Anxiety: A Review | Pharmacology | 1983 | 194 |
| 15 | Receptors for Substance P and Related Neurokinins | Pharmacology | 1989 | 189 |
| 16 | Antioxidant and Radical Scavenging Effects of Anthraquinones and Anthrones | Pharmacology | 1993 | 185 |
| 17 | Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man | Pharmacology | 1979 | 181 |
| 18 | Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics | Pharmacology | 2010 | 180 |
| 19 | Human Serum Albumin as a ‘Silent Receptor’ for Drugs and Endogenous Substances | Pharmacology | 1979 | 174 |
| 20 | Anti-Inflammatory Activity of Thymol: Inhibitory Effect on the Release of Human Neutrophil Elastase | Pharmacology | 2006 | 168 |
| 21 | Resveratrol, a Polyphenolic Phytoalexin, Attenuates Diabetic Nephropathy in Rats | Pharmacology | 2006 | 158 |
| 22 | The CYP2C19 Enzyme Polymorphism | Pharmacology | 2000 | 153 |
| 23 | Genetic Polymorphism of Thiopurine S-Methyltransferase: Molecular Mechanisms and Clinical Importance | Pharmacology | 2000 | 152 |
| 24 | Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response | Pharmacology | 2008 | 150 |
| 25 | Polymorphisms of Human Aldehyde Dehydrogenases | Pharmacology | 2000 | 145 |
| 26 | Acetyltransferase in Humans: Development and Tissue Distribution | Pharmacology | 1986 | 143 |
| 27 | The Prevention of Acute Gastric Ulcer in the Rat by α-Methyldopa | Pharmacology | 1967 | 133 |
| 28 | Pharmacogenetics of Beta-1- and Beta-2-Adrenergic Receptors | Pharmacology | 2000 | 133 |
| 29 | The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin | Pharmacology | 1972 | 132 |
| 30 | Antiulcer Effect of Naringin on Gastric Lesions Induced by Ethanol in Rats | Pharmacology | 1994 | 131 |
| 31 | Behavioral Evaluation of Male and Female Mice Pups Exposed to Fluoxetine during Pregnancy and Lactation | Pharmacology | 2007 | 131 |
| 32 | Bromobenzene Metabolism and Hepatic Necrosis | Pharmacology | 1971 | 130 |
| 33 | Daptomycin: A Review 4 Years after First Approval | Pharmacology | 2008 | 130 |
| 34 | The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function | Pharmacology | 2009 | 130 |
| 35 | Explaining the Escalation of Drug Use in Substance Dependence: Models and Appropriate Animal Laboratory Tests | Pharmacology | 2007 | 127 |
| 36 | Neuroprotective Effects of Resveratrol against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress in Rats | Pharmacology | 2007 | 127 |
| 37 | Structure-Activity Relationships in Man of Cannabis Constituents, and Homologs and Metabolites of Δ<sup>9</sup>-Tetrahydrocannabinol | Pharmacology | 1974 | 125 |
| 38 | Suppressive Effects of Eugenol and Ginger Oil on Arthritic Rats | Pharmacology | 1994 | 125 |
| 39 | Effects of Ginger on Motion Sickness Susceptibility and Gastric Function | Pharmacology | 1991 | 124 |
| 40 | Antiulcer and Gastroprotective Effects of Quercetin: A Gross and Histologic Study | Pharmacology | 1994 | 124 |
| 41 | Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy | Pharmacology | 2008 | 124 |
| 42 | Benzodiazepine Side Effects: Role of Pharmacokinetics and Pharmacodynamics | Pharmacology | 1995 | 122 |
| 43 | The Evolution of Drug Metabolism | Pharmacology | 2000 | 121 |
| 44 | G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium | Pharmacology | 2010 | 120 |
| 45 | β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway | Pharmacology | 2014 | 120 |
| 46 | Anesthetic, Hypothermic, Myorelaxant and Anticonvulsant Effects of Synthetic Eugenol Derivatives and Natural Analogues | Pharmacology | 1981 | 119 |
| 47 | Effects of Ginsenoside Rbi on Central Cholinergic Metabolism | Pharmacology | 1991 | 117 |
| 48 | Release of Vasoactive Substances from Guinea-Pig Lungs by Slow-Reacting Substance C and Arachidonic Acid | Pharmacology | 1971 | 114 |
| 49 | The Echinocandins: Comparison of Their Pharmacokinetics, Pharmacodynamics and Clinical Applications | Pharmacology | 2006 | 114 |
| 50 | 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and Rat | Pharmacology | 1986 | 113 |
